Medicine and Dentistry
Acupuncture
15%
Adverse Effect
16%
Adverse Event
21%
Analgesia
8%
Analysis of Variance
15%
Arm
7%
Arthralgia
8%
Botulinum Toxin
46%
Botulinum Toxin A
100%
Bruxism
27%
Catastrophizing
7%
Clinical Trial
39%
Clostridium Botulinum Type A
30%
Controlled Clinical Trial
9%
Counseling
9%
Cross Sectional Study
9%
Echography
12%
Hypervigilance
7%
Jaw
12%
Jaw Disease
40%
Jaw Muscle
7%
Malocclusion
7%
Masseter Muscle
25%
Masticatory Force
17%
Masticatory Muscle
26%
Meta-Analysis
11%
Muscle Contraction
14%
Myofascial Pain
57%
Nociception
15%
Oral Appliance
8%
Oral Hygiene
15%
Orofacial Pain
9%
Pain Catastrophizing
8%
Physical Activity
8%
Physical Activity Level
7%
Pittsburgh Sleep Quality Index
10%
Pressure Pain Threshold
29%
Randomized Clinical Trial
31%
Randomized Controlled Trial
20%
Sleep Bruxism
8%
Sleep Quality
8%
Stomatitis
7%
Systematic Review
44%
Temporalis Muscle
22%
Temporomandibular Joint
33%
Temporomandibular Joint Disc
7%
Temporomandibular Joint Disorder
14%
Trigeminal Neuralgia
15%
Umbrella Review
7%
Visual Analog Scale
14%
Nursing and Health Professions
Arthralgia
9%
Botulinum Toxin A
30%
Botulinum Toxin Type A
23%
Bruxism
7%
Catastrophizing
23%
Chi Square Test
6%
Chronic Pain
8%
Clinical Indicator
7%
Clostridium Botulinum Type A
7%
Electromyography
5%
Female Patient
5%
Hormone Substitution
7%
Hypobarism
9%
Interstitial Collagenase
7%
Jaw Disease
46%
Kinesiophobia
12%
Meta Analysis
8%
Myofascial Pain
24%
Pain Intensity
8%
Pain Threshold
14%
Palpation
6%
Partial Coherence Interferometry Biometer
9%
Perceived Stress Scale
5%
Pilot Study
7%
Pittsburgh Sleep Quality Index
12%
Pressure Pain Threshold
39%
Prevalence
19%
Research Diagnostic Criteria
5%
Sleep Quality
10%
Somatization
15%
State Trait Anxiety Inventory
10%
Systematic Review
15%
Temporomandibular Joint Disorder
7%
Tinnitus
6%
Tumor Necrosis Factor
7%
Visual Analog Scale
5%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
9%
Arthritis
7%
Botulinum Toxin
15%
Botulinum Toxin A
21%
Bruxism
23%
Candida
7%
Catastrophizing
21%
Clinical Trial
8%
Clostridium Botulinum Type A
7%
Cross-Sectional Study
6%
Dopamine Receptor Stimulating Agent
5%
Jaw Disease
42%
Kynurenine
5%
Lipoatrophy
7%
Musculoskeletal Pain
7%
Myofascial Pain
8%
Normal Human
7%
Polylactic Acid
7%
Prevalence
24%
Psychogenic Pain
5%
Randomized Clinical Trial
9%
Randomized Controlled Trial
5%
Replacement Therapy
7%
Serotonin
6%
Sleep Bruxism
5%
Stomatitis
7%
Temporomandibular Joint Disorder
11%
Tinnitus
6%
Trigeminus Neuralgia
7%
Tryptophan
7%